[{"Assets_0_Q2_USD":"2607185000.0","CIK":"874716","CommonStockSharesIssued_0_Q2_shares":"107075000.0","CommonStockSharesOutstanding_0_Q2_shares":"83428000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"1.57","EarningsPerShareBasic_2_Q2_USD":"3.87","EarningsPerShareDiluted_1_Q2_USD":"1.56","EarningsPerShareDiluted_2_Q2_USD":"3.82","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"42180715521.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"180556000.0","NetIncomeLoss_1_Q2_USD":"131979000.0","NetIncomeLoss_2_Q2_USD":"325944000.0","OfficialName":"IDEXX Laboratories Inc. Common Stock","ProfitLoss_1_Q2_USD":"131979000.0","ProfitLoss_2_Q2_USD":"325944000.0","RevenuesConverted_1_Q2_USD":"860546000.0","RevenuesConverted_2_Q2_USD":"1697095000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"457008000.0","StockholdersEquity_0_Q2_USD":"457008000.0","Ticker":"IDXX","TreasuryStockSharesConverted_0_Q2_shares":"23647000.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"84858000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"85222000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"83922000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"84164000.0","filed":"20220802","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"IDEXX LABORATORIES INC \/DE","period":"20220630","qtrs":"0","uom":"USD"}]